ClinicalTrials.Veeva

Menu

Osteofibrous Dysplasia (Kempson-Campanacci's Disease) (DOFOL)

I

Istituto Ortopedico Rizzoli

Status

Completed

Conditions

Osteofibrous Dysplasia

Treatments

Behavioral: study of osteofibrous dysplasia features

Study type

Observational

Funder types

Other

Identifiers

NCT04104763
9261_2019

Details and patient eligibility

About

The aim of the present study is to obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.

Enrollment

50 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female patients treated at Rizzoli Institute from 01 Jan 1943 to 31 Dic 2011
  • Diagnosis of osteofibrous dysplasia pathologically confirmed
  • Written informed consent prior to any study-specific analysis and/or data collection

Exclusion criteria

  • Patients with histological diagnosis different from osteofibrous dysplasia

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems